FTC sues main pharmacy advantage supervisors above insulin rates The agency brought motion in opposition to Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing price of lifestyle-preserving insulin medications. Elevance lowers advice on ‘unprecedented’ Medicaid problems Executives explained the enhance... https://codywmduj.blogoscience.com/36779861/healthcare-news-an-overview